OX2 Therapeutics' Unattributed Round

OX2 Therapeutics raised a round of funding on May 17, 2017.

OX2 Therapeutics aims to make a transformative impact in the treatment of primary brain tumors and other central nervous system tumors.…

Articles about OX2 Therapeutics' Unattributed Round: